Coronary heart disease (CHD)
Conditions
Interventions
Group 4:Conventional medication plus 18 days of EECP
Group 1:Conventional drug therapy
Group 2:Conventional medication plus 6 days of EECP
Group 3:Conventional medication plus 12 days of EECP
Group 5:Conventional medication plus 35 days of EECP
Sponsors
Gansu Provincial Hospital
Eligibility
Sex/Gender
All
Age
18 Years to 85 Years
Inclusion criteria
Inclusion criteria: 1.At least 18 years of age; 2.patients with coronary artery disease confirmed by coronary angiography; 3.Patients informed and agreed to participate in this study.
Exclusion criteria
Exclusion criteria: 1. Patients with various bleeding disorders or bleeding tendency; 2. Patients with active thrombophlebitis; 3. Patients with decompensated heart failure; 4. Those with moderate to severe aortic regurgitation; 5. Patients with dissecting aneurysms; 6. Patients with significant pulmonary hypertension; 7. Uncontrolled hypertension (blood pressure>180/100mmHg); 8. Patients with severe arrhythmia and severe heart failure (cardiac function class III-IV) that affect counterpulsation therapy; 9. Patients with severe liver and kidney failure; 10. Pregnant patients.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 6 minutes walking distance;Platelet aggregation;The number of angina attacks;Various cardiac function indicators;Left ventricular ejection fraction;Ability to live daily, anxiety, depression, cognitive function, sleep quality, and quality of life scores;Microalbuminuria, insulin levels, aldosterone content;Cardiac autonomic function (heart rate variability and catecholamine content);Changes of serum inflammatory factors; | — |
Countries
China
Contacts
Public ContactZhang Juxia
Gansu Provincial People's Hospital
Outcome results
None listed